USA Compression director receives 4,338 restricted common units

USA Compression Partners, LP reported an equity award to one of its directors.

Rhea-AI Filing Summary

USA Compression Partners, LP reported an equity award to one of its directors. On 01/02/2026, the reporting person received 4,338 common units of USA Compression Partners, LP at a price of $0, increasing their beneficial ownership to 11,332 units held directly.

The award consists of restricted units granted under the USA Compression Partners, LP Long-Term Incentive Plan. These units are scheduled to vest 60% on December 5, 2028 and 40% on December 5, 2030, generally contingent on the director’s continued employment with USA Compression Partners, LP or its affiliates on each vesting date. The reporting person serves as a director of USA Compression GP, LLC, the general partner that manages USA Compression Partners, LP.

Insider Trade Summary

Grant/Award: 4,338 shares

Grant/Award 1 txn

Insider Wortham John L.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Units	4,338	$0.00	$0.00

Holdings After Transaction: Common Units — 11,332 shares (Direct)

Footnotes (1)

1. F1. An award of Restricted Units granted under the USA Compression Partners, LP Long-Term Incentive Plan that will vest 60% on December 5, 2028 and 40% on December 5, 2030, generally contingent upon the Reporting Person's continued employment with USA Compression Partners, LP (the "Issuer") or one of its affiliates on each applicable vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did USA Compression Partners, LP (USAC) disclose?

The company disclosed that a director received an award of 4,338 common units of USA Compression Partners, LP on 01/02/2026, increasing their beneficial ownership to 11,332 units held directly.

What type of equity was granted in this USA Compression Partners, LP (USAC) Form 4?

The filing reports an award of restricted units of USA Compression Partners, LP common units granted under the USA Compression Partners, LP Long-Term Incentive Plan.

How do the restricted units for the USA Compression Partners, LP (USAC) director vest?

The restricted units will vest 60% on December 5, 2028 and 40% on December 5, 2030, generally contingent on the director’s continued employment with USA Compression Partners, LP or one of its affiliates on each vesting date.

What is the reported acquisition price of the USA Compression Partners, LP (USAC) units?

The Form 4 shows that the 4,338 common units were acquired at a reported price of $0, consistent with a compensatory restricted unit grant.

What is the reporting person’s role at USA Compression Partners, LP (USAC)?

The reporting person is a director of USA Compression GP, LLC, which is the general partner of USA Compression Partners, LP and manages the partnership through its directors and executive officers.

Does this USA Compression Partners, LP (USAC) Form 4 involve derivative securities?

The provided portion of the filing includes an empty table for derivative securities and only reports a transaction in non-derivative common units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/06/2026 - 05:07 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wortham John L.

(Last) (First) (Middle)

C/O USA COMPRESSION PARTNERS, LP

8115 PRESTON ROAD, SUITE 700

(Street)

DALLAS TX 75225

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USA Compression Partners, LP [ USAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Units	01/02/2026		A		4,338(1)	A	$0	11,332	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. An award of Restricted Units granted under the USA Compression Partners, LP Long-Term Incentive Plan that will vest 60% on December 5, 2028 and 40% on December 5, 2030, generally contingent upon the Reporting Person's continued employment with USA Compression Partners, LP (the "Issuer") or one of its affiliates on each applicable vesting date.

Remarks:

The Reporting Person is a director of USA Compression GP, LLC, the general partner (the "General Partner") of the Issuer. The Issuer is managed by the directors and executive officers of the General Partner.

	/s/ John L. Wortham	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.